Forte Biosciences, Inc.
Key Metrics
Market Snapshot
About
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for dermatological diseases. The company's lead product candidate FB-401 is a live biotherapeutic being developed for the treatment of pediatric atopic dermatitis (eczema). Forte's approach involves topical application of certain bacterial strains intended to restore skin microbiome balance and modulate immune responses. The company is conducting clinical trials to evaluate the safety and efficacy of its investigational treatments in patients with inflammatory skin conditions.